Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 11Recruiting 10Active not recruiting 4Unknown 3Terminated 3Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Breast 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Prostatic Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Carboplatin 58Cisplatin 39Drug Therapy 37Pemetrexed 36osimertinib 22anlotinib 22Etoposide 19tislelizumab 17Surgical Procedures, Operative 16Paclitaxel 16Radiotherapy 15toripalimab 14Docetaxel 14pembrolizumab 13130-nm albumin-bound paclitaxel 13Bevacizumab 12aflutinib 11sintilimab 10Specimen Handling 10durvalumab 9Magnetic Resonance Spectroscopy 9cemiplimab 8Platinum 8Injections 8Immunotherapy 8Platinum Compounds 7PM 01183 7Blood Specimen Collection 7ensartinib 6atezolizumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × X-Rays × Thoracic × Clear all
NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
24 enrolled
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡